Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 7, 2025 • 5:00 AM ET

Date/Time Source News Release
05/07/2024 07:00 AM EDT GlobeNewswire Orchard Therapeutics Announces Multiple Presentations at ASGCT 2024
05/03/2024 07:00 AM EDT GlobeNewswire Orchard Therapeutics Co-founder and Chief Executive Officer Dr. Bobby Gaspar Named to Inaugural 2024 TIME100 Health List
03/20/2024 07:00 AM EDT GlobeNewswire Orchard Therapeutics Outlines U.S. Launch Plans for Lenmeldy(TM) (atidarsagene autotemcel), the Only Approved Therapy for Children with Early-onset Metachromatic Leukodystrophy
03/18/2024 03:41 PM EDT GlobeNewswire Orchard Therapeutics Receives FDA Approval of Lenmeldy(TM) (atidarsagene autotemcel), the Only Therapy for Eligible Children with Early-onset Metachromatic Leukodystrophy in the U.S.
02/05/2024 07:00 AM EST GlobeNewswire Orchard Therapeutics Announces First Patient Randomized in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome
02/02/2024 07:00 AM EST GlobeNewswire Orchard Therapeutics Announces Multiple Presentations at the 20th Annual WORLDSymposium
01/25/2024 07:00 AM EST GlobeNewswire Orchard Therapeutics Announces Agreement with the Beneluxa Consortium Enabling Reimbursed Access to Libmeldy
01/24/2024 05:00 AM EST GlobeNewswire Kyowa Kirin successfully completes acquisition of Orchard Therapeutics, a global gene therapy leader for rare diseases
12/11/2023 07:00 AM EST GlobeNewswire Orchard Therapeutics Receives Swissmedic Approval for Libmeldy in Early-onset MLD
11/30/2023 07:00 AM EST GlobeNewswire Orchard Therapeutics Receives U.S. FDA Fast Track Designation for OTL-203 in MPS-IH
Page

Additional News

As of June 7, 2025 • 5:00 AM ET

Date/Time Source News Release
03/04/2024 06:00 AM EST US Earnings Reports Expected US Company Earnings on Monday, March 4th, 2024
03/04/2024 04:55 AM EST US Earnings Reports Expected earnings - Orchard Therapeutics plc
01/19/2024 01:34 PM EST SeekingAlpha Orchard Therapeutics: Still An Attractive Merger Arbitrage Opportunity With A CVR
12/21/2023 07:40 AM EST Stock Traders Daily (ORTX) Investment Report
12/15/2023 03:10 PM EST SeekingAlpha Catalyst Watch: Spotlight on FedEx, Nike, Micron and gold stocks
12/04/2023 07:02 AM EST SeekingAlpha Why The Small Orchard Therapeutics Buyout Is Worth A Look
11/30/2023 07:24 AM EST SeekingAlpha Orchard Therapeutics gains FDA fast track status for Hurler syndrome therapy
11/21/2023 08:46 AM EST SeekingAlpha Orchard says no FDA AdCom for gene therapy approval
11/19/2023 07:11 AM EST SeekingAlpha Top Merger Stocks Held By Fund Managers, Mid-Q4 2023
11/13/2023 07:20 AM EST SeekingAlpha Orchard Therapeutics GAAP EPS of -$0.15 beats by $0.30, revenue of $6.3M misses by $1.6M
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.